Source link : https://www.newshealth.biz/health-news/fda-approves-new-treatment-for-excessive-underarm-sweating/
The Food and Drug Administration has approved a topical anticholinergic, sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis in adults and children aged ≥ 9 years. According to a press release from Botanix Pharmaceuticals, which developed the product and will market it under the brand name Sofdra, approval was based on results […]
Author : News Health
Publish date : 2024-06-25 12:25:13
Copyright for syndicated content belongs to the linked Source.
Categories